| 801 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
77 |
| 802 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
23 |
| 803 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
58 |
| 804 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
United Kingdom
|
53 |
| 805 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
75 |
| 806 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
61 |
| 807 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
8 |
| 808 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
63 |
| 809 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Ukraine
|
38 |
| 810 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
70 |
| 811 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
69 |
| 812 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
31 |
| 813 |
Bone Marrow Family |
Allogeneic
|
Acute Myleogenous Leukemia, alloPBST 7/2025
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
53 |
| 814 |
Bone Marrow |
Allogeneic
|
Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Spain
|
15 |
| 815 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Norway
|
55 |
| 816 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy
|
France
|
3 |
| 817 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
7 |
| 818 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Ukraine
|
36 |
| 819 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy
|
France
|
10 |
| 820 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
76 |
| 821 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
39 |
| 822 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
South Africa
|
6 |
| 823 |
Bone Marrow |
Allogeneic
|
Wiskott-Aldrich syndrome
|
Hematology
|
2025
|
Standard Therapy
|
Turkey
|
6 |
| 824 |
Bone Marrow |
Allogeneic
|
Combined immnunodeficiency
|
Hematology
|
2025
|
Standard Therapy
|
Ukraine
|
3 |
| 825 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
3 |
| 826 |
Bone Marrow |
Allogeneic
|
Mixed Phenotype Acute Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
13 |
| 827 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
7 |
| 828 |
Bone Marrow |
Allogeneic
|
B-cell precursor Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
56 |
| 829 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
43 |
| 830 |
Bone Marrow |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
19 |
| 831 |
Bone Marrow |
Allogeneic
|
Very Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
12 |
| 832 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
5 |
| 833 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
10 |
| 834 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
6 |
| 835 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
44 |
| 836 |
Bone Marrow |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
25 |
| 837 |
Bone Marrow |
Allogeneic
|
Juvenile Myelomonocytic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
4 |
| 838 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
21 |
| 839 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
12 |
| 840 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Hungary
|
10 |
| 841 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Czechia
|
68 |
| 842 |
Bone Marrow |
Allogeneic
|
Adrenoleukodystrophy
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
53 |
| 843 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
4 |
| 844 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
4 |
| 845 |
Bone Marrow |
Allogeneic
|
Paroxysmal Nocturnal Hemoglobinuria
|
Hematology
|
2025
|
Standard Therapy
|
Norway
|
18 |
| 846 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Spain
|
24 |
| 847 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Belarus
|
5 |
| 848 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
53 |
| 849 |
Bone Marrow |
Allogeneic
|
diamond-Balckfan anemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
11 |
| 850 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
57 |
| 851 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
61 |
| 852 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
3 |
| 853 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Belarus
|
1 |
| 854 |
Bone Marrow |
Allogeneic
|
pB-Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
15 |
| 855 |
Bone Marrow |
Allogeneic
|
OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein
|
Hematology
|
2025
|
Standard Therapy
|
Switzerland
|
2 |
| 856 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
46 |
| 857 |
Bone Marrow |
Allogeneic
|
Acquired Idiopathic Sideroblastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Russian Federation
|
5 |
| 858 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
10 |
| 859 |
Bone Marrow |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
47 |
| 860 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
CROATIA
|
11 |
| 861 |
Bone Marrow |
Allogeneic
|
Juvenile myelomonocytic leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
5 |
| 862 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Brazil
|
12 |
| 863 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Australia
|
8 |
| 864 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
3 |
| 865 |
Bone Marrow |
Allogeneic
|
Myelodysplatic Syndrome
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
60 |
| 866 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Russia
|
36 |
| 867 |
Bone Marrow |
Allogeneic
|
Thalassemia major
|
Hematology
|
2025
|
Standard Therapy
|
Turkey
|
10 |
| 868 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
58 |
| 869 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
2 |
| 870 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
18 |
| 871 |
Bone Marrow |
Allogeneic
|
Other Non-Malignant Disease, Specify
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
17 |
| 872 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
15 |
| 873 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
15 |
| 874 |
Bone Marrow |
Allogeneic
|
aplastic anemia
|
Hematology
|
2025
|
Standard Therapy
|
Belgium
|
36 |
| 875 |
Bone Marrow |
Allogeneic
|
Primary Refractory
|
Hematology
|
2025
|
Standard Therapy
|
Ireland
|
27 |
| 876 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
39 |
| 877 |
Bone Marrow |
Allogeneic
|
Sickle Cell Disease (SCD)
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
8 |
| 878 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
68 |
| 879 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
58 |
| 880 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
1 |
| 881 |
Bone Marrow |
Allogeneic
|
Severe Combined Immunodeficiency
|
Hematology
|
2025
|
Standard Therapy
|
United Kingdom
|
13 |
| 882 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Denmark
|
38 |
| 883 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
17 |
| 884 |
Bone Marrow |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
11 |
| 885 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
9 |
| 886 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
3 |
| 887 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
9 |
| 888 |
Bone Marrow |
Allogeneic
|
Fanconi Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Poland
|
8 |
| 889 |
Bone Marrow |
Allogeneic
|
Immune Deficiency
|
Hematology
|
2025
|
Standard Therapy
|
United Kingdom
|
10 |
| 890 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
12 |
| 891 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
USA
|
20 |
| 892 |
Bone Marrow |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2025
|
Standard Therapy
|
Turkey
|
17 |
| 893 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
France
|
13 |
| 894 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Canada
|
22 |
| 895 |
Bone Marrow |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Germany
|
15 |
| 896 |
Bone Marrow |
Allogeneic
|
Severe Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
8 |
| 897 |
Bone Marrow |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2025
|
Standard Therapy
|
France
|
3 |
| 898 |
Bone Marrow |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
2 |
| 899 |
Bone Marrow |
Allogeneic
|
Bone Marrow Failure
|
Hematology
|
2025
|
Standard Therapy
|
Netherlands
|
23 |
| 900 |
Bone Marrow |
Allogeneic
|
Chronic Granulomatous Disease
|
Hematology
|
2025
|
Standard Therapy
|
Italy
|
6 |